Pono Capital Corp. (NASDAQ:PONO) disclosed in an 8-K filing this morning that its shareholders approved its combination with air mobility company AERWINS at a special meeting held on Friday, January 27.
Holders of 12,412,861 common shares were present at the meeting and the deal was approved with 11,218,712 shares in favor of the transaction.
The filing did not include redemption figures or a closing timeline, but once closed, the combined company is expected to list on the NASDAQ Capital Market under the symbols “AWIN” and “AWINW”.
Pono announced its $750 million deal with AERWINS in September 2022. Tokyo, Japan-based AERWINS develops technology that enables air mobility such as a luxury hoverbike and drone-based solution services.
The SPAC originally intended to combine with cannabinoid drug developer Benuvia in a deal valued at $440 million. Pono announced the combination in March 2022, but it was terminated several months later in August 2022 without revealing much detail. At that time, the company faced a completion deadline of August 13, 2022, but was able to extend its timeline twice for a final deadline of February 11, 2023.
Pono’s CEO and Founder Dustin Shindo is also Chairman of Pono Capital Two (NASDAQ:PTWOU) and Pono Capital Three (NASDAQ:PTHR).
Real estate marketplace Opendoor (NASDAQ:OPEN) is poised to be the latest de-SPAC to take a double-digit jump on earnings as it heads towards the weekend up +10%, having spiked as high as +27% earlier in the day. The movement comes as the former Social Capital II target reported progress towards profitability despite a high rates...
At the SPAC of Dawn Coinbase (NASDAQ:COIN) notched a surprise profit of over $1.5 billion in the first quarter of 2024, well exceeding estimates, demonstrating the powerful effect of publicly traded ETFs have had on crypto marketplaces since the start of the year. The result has pushed the company to bump up its own guidance...
Online casino and sports company Rush Street (NYSE:RSI) is up +18.4% in trading today on the back of a solid first quarter earnings release, bringing the company’s stock to its highest price since the second half of 2022 (currently $7.60). This makes it the latest in a line of 2020 and 2021 de-SPACs that have...
Mountain Crest V (NASDAQ:MCAG) broke a long dealmaking silence by SPACs this morning, albeit with a non-binding agreement to combine with Seoul-based diagnostic biotech firm CUBEBIO. The term sheet would give the company a $620 million pre-transaction equity value and help accelerate the rollout of CUBEBIO’s CEED-NOVUS cancer screening kit products. The company signed an...
Churchill Capital Corp IX (NASDAQ:CCIXU) announced the pricing of its $250 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “CCIXU”, Thursday, May 2, 2024. The new SPAC will conduct a broad search and has not limited itself to any particular sector or focus, but it plans to...